MRI Scan for Kidney Problems

Your kidneys filter around 180 litres of blood every day, removing waste and maintaining fluid balance. Kidney problems are common — chronic kidney disease affects approximately 3 million people in the UK, and kidney cancer accounts for around 13,000 new diagnoses each year. MRI is a valuable tool for investigating kidney problems, offering detailed images of kidney structure, blood supply, and surrounding tissues without radiation or the iodinated contrast agents used in CT that can be harmful to compromised kidneys.

If blood tests have shown abnormal kidney function, if you have blood in your urine, flank pain, or a kidney mass found on ultrasound, an MRI can provide the detailed assessment your urologist or nephrologist needs.

Common Kidney Problems MRI Can Assess

Kidney Masses and Cysts

MRI is the best imaging test for characterising kidney masses — determining whether they are benign or potentially cancerous:

• Simple cysts — extremely common (found in 50% of people over 50). Appear as round, fluid-filled structures with thin walls and no enhancement after contrast. Bosniak classification I — benign, no follow-up needed.
• Complex cysts — cysts with thick walls, septations, calcification, or enhancing components. Classified using the Bosniak system (I-IV):
  • Bosniak I/II: benign. No action needed.
  • Bosniak IIF: probably benign. Follow-up imaging recommended.
  • Bosniak III: indeterminate. Approximately 50% chance of malignancy. Surgery or biopsy often recommended.
  • Bosniak IV: almost certainly malignant. Surgical removal recommended.
• Solid masses (renal cell carcinoma) — MRI with contrast shows enhancement pattern, involvement of the renal vein and inferior vena cava (tumour thrombus), and relationship to surrounding structures. Around 13,000 kidney cancers are diagnosed annually in the UK.
• Angiomyolipoma (AML) — benign tumours containing fat, blood vessels, and smooth muscle. MRI detects the fat content (bright on T1, signal loss on fat-saturated images), which is the distinguishing feature. Large AMLs (over 4cm) may need treatment due to bleeding risk.
• Oncocytoma — benign solid tumour that can mimic renal cell carcinoma on imaging. MRI features can suggest oncocytoma (central scar, homogeneous enhancement) but definitive diagnosis often requires biopsy or surgical removal.

Other Kidney Conditions

• Hydronephrosis — dilation of the kidney's collecting system due to obstruction (kidney stones, tumour, stricture). MRI shows the cause and level of obstruction.
• Pyelonephritis (kidney infection) — MRI shows patchy enhancement and oedema in the kidney. Can detect complications such as abscess formation.
• Polycystic kidney disease (PKD) — autosomal dominant PKD affects 1 in 1,000 people. MRI shows kidney size, number and size of cysts, and total kidney volume — which is used to assess disease progression and eligibility for tolvaptan treatment.
• Renal artery stenosis — MR angiography (MRA) can assess the renal arteries non-invasively for narrowing, particularly relevant in resistant hypertension.
• Kidney stones — actually one of the few things MRI is NOT good at detecting. CT is far superior for kidney stones. MRI can sometimes show larger stones as signal voids, but small stones are usually missed.

Why MRI Over CT for Kidneys?

Both MRI and CT are excellent for kidney imaging, but MRI has specific advantages:

• No radiation — important for patients needing repeated imaging (monitoring cysts, PKD follow-up).
• Better tissue characterisation — MRI is superior at distinguishing between different types of kidney masses (cyst vs solid, fat-containing vs non-fat-containing).
• Safe contrast — gadolinium (MRI contrast) is less nephrotoxic than iodinated contrast (CT contrast). MRI can often be performed without contrast at all for cyst characterisation.
• Tumour thrombus assessment — MRI is the best test for showing whether a kidney cancer has extended into the renal vein or inferior vena cava.

CT is better for: kidney stones, acute renal colic, initial staging of many urological cancers, and rapid assessment in emergencies.

What to Expect

A kidney MRI takes 25-40 minutes. You lie on your back with a coil over your abdomen. Breath-holds (10-15 seconds) are required for some sequences. If contrast is used, you will have a cannula in your arm.

Preparation

• You may be asked to fast for 4-6 hours if contrast is planned
• A recent kidney function blood test (eGFR) may be needed for contrast, especially if you have known kidney disease
• Gadolinium contrast is generally safe in normal kidney function but used with caution (or avoided) in severe kidney impairment (eGFR below 30) due to the rare risk of nephrogenic systemic fibrosis (NSF)

What MRI Cannot Show

• Kidney stones — CT without contrast (CT KUB) is the gold standard for stone detection. MRI misses most stones.
• Detailed pelvicalyceal anatomy — CT urography is better for mapping the collecting system, ureters, and bladder.
• Definitive mass diagnosis — while MRI can characterise masses accurately, definitive diagnosis of solid masses often requires biopsy or surgical removal for histological analysis.

Treatment Pathways

• Simple cysts — no treatment needed. Monitor only if very large and causing symptoms (aspiration or surgery rarely needed).
• Renal cell carcinoma — partial nephrectomy (removing part of the kidney) for small tumours (under 7cm). Radical nephrectomy (removing the entire kidney) for larger tumours. Active surveillance may be appropriate for small tumours in elderly patients. Targeted therapies and immunotherapy for metastatic disease. 5-year survival for localised disease: approximately 90%.
• AML — monitoring if small. Embolisation (blocking blood supply) or partial nephrectomy if over 4cm due to bleeding risk.
• PKD — blood pressure control, tolvaptan (slows cyst growth and kidney function decline in ADPKD). Renal replacement therapy (dialysis or transplant) for end-stage disease.
• Renal artery stenosis — medical management (antihypertensives, statins) for most patients. Renal artery stenting has not shown significant benefit over medical therapy in most studies.

UK Statistics

• Chronic kidney disease affects approximately 3 million people in the UK
• Kidney cancer: around 13,000 new diagnoses per year
• Kidney cancer 5-year survival: approximately 65% overall, 90%+ for localised disease
• Autosomal dominant PKD affects approximately 1 in 1,000 people
• Simple kidney cysts are found in about 50% of people over 50

Frequently Asked Questions

Related Blood Tests

• Kidney function (creatinine, eGFR) — the baseline test for kidney health
• Urine analysis — protein and blood in urine
• Full blood count — anaemia is common in chronic kidney disease
• Calcium, phosphate, and vitamin D — often abnormal in kidney disease

Browse Lola Health blood tests

Related Articles

• Can an MRI Detect Cancer?
• Fatty Liver Disease MRI
• Crohn's Disease MRI